WHO Drafting Group Agrees Resolution On Health R&D 28/05/2016 by William New, Intellectual Property Watch 1 Comment A closed-door drafting group this evening arrived seemingly easily at agreement on a resolution on broadening work on new ways to fund research and development into medical products, according to participants. The agreement includes the creation of a new expert committee on health R&D, and asks for a WHO proposal on a pooled fund, they said. [Update: draft text now available]
Global Health In The Glare In G7 Final Resolutions; Trade Deals Promised For 2016 27/05/2016 by Monika Ermert for Intellectual Property Watch Leave a Comment Reform of the WHO, support for the Contingency Fund for Emergency to enable swift initial responses by the WHO, and a special R&D and innovation chapter in the G7 Ise-Shima Vision for Global Health that does not include the word intellectual property are some of the notables after the G7 Summit closed today in Japan. Counting pages, Global Health and lessons from the recent Ebola and Zika outbreaks did receive the biggest attention. But the G7 would not be its old usual without considerable warnings and some concrete proposals how to fight global terrorism and violent extremism.
WHO Reforms Health Emergency Response But Who Will Pay The Bill? 27/05/2016 by Mara Pillinger for Intellectual Property Watch Leave a Comment Two years after Ebola, the World Health Organization continues to push forward with a thorough overhaul of how it responds to health emergencies. These include Public Health Emergencies of International Concern (PHEICs), such as the Ebola and Zika outbreaks, as well as natural diseases, conflicts, refugee crises, and the like.
Drafting Group Finishes Framework On WHO And Outside Actors 27/05/2016 by Catherine Saez, Intellectual Property Watch 1 Comment If adopted as expected tomorrow by the World Health Assembly, a framework guiding the relationships between the World Health Organization and outside actors will be the first of its kind in the United Nations system, according to sources.
Europe Medicines Group Joins Initiative To Fight Fake Medicines 27/05/2016 by Intellectual Property Watch 1 Comment Medicines for Europe, representing the generic, biosimilar, and medicines in Europe, announced today during a side event at the World Health Assembly, that it joined the Global Campaign to Fight Fake Medicines.
Resolution On WHO Work With Non-State Actors Down To Wire 27/05/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment With the end of the annual World Health Assembly looming tomorrow, member states are working away behind closed doors to finalise a resolution on how the World Health Organization shall work with outside actors going forward.
EU Council Green-Lights Trade Secrets Directive 27/05/2016 by Dugie Standeford for Intellectual Property Watch Leave a Comment The European Union trade secrets directive passed its final hurdle on 27 May when EU governments backed compromise text approved by the European Parliament on 14 April. Once the law has been formally published, member states will have up to two years to incorporate its provisions into domestic law.
Against Microbial Resistance Peril, WHA Delegates Discuss Global Solutions, Approve Report 27/05/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment According to a new report, by 2050, some 10 million lives could be lost a year due to antimicrobial resistance. This is an issue which has been central to this year’s World Health Assembly, and is of global consequence. Delegates gathered for the occasion noted a report by the World Health Organization secretariat on the global action plan on antimicrobial resistance adopted last year and options to develop a global stewardship framework to try to limit the use of antibiotics and develop new ones.
National And Regional Initiatives To Spur Research For New Antibiotics 27/05/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment A side event to the World Health Assembly organised by a number of delegations on antibiotic research and innovation reflected the deep global concern about antimicrobial resistance and the lack of candidates to replace what was once considered as a miracle of modern medicine.
Shift In Discussions About R&D At This Week’s World Health Assembly 26/05/2016 by William New, Intellectual Property Watch 1 Comment Public health advocates – and many nations – had high hopes that this year’s World Health Assembly could finally agree on some alternative ways to fund research and development that leads to affordable medical products by de-linking R&D costs from prices, through the long-awaited discussion of a landmark 2012 report of a WHO expert group on medical R&D. This week, that discussion has spread across the highest profile topics of the week such as antimicrobial resistance and emergencies, but some are concerned that the public health safeguards recommended by the expert group may be being left behind.